title: A pentamidine-treated acquired immunodeficiency syndrome patient associated with sudden onset diabetes mellitus and high tumor necrosis factor alpha level.
authors.affiliation: Department of Internal Medicine, Teikyo University School of Medicine, Ichihara Hospital, Chiba, Japan.
authors.forename: E
authors.initials: E
authors.lastname: Ubukata
authors.forename: O
authors.initials: O
authors.lastname: Mokuda
authors.forename: M
authors.initials: M
authors.lastname: Nagata
authors.forename: Y
authors.initials: Y
authors.lastname: Ogino
authors.forename: Y
authors.initials: Y
authors.lastname: Sakamoto
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
authors.forename: N
authors.initials: N
authors.lastname: Shimizu
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D003920:Diabetes Mellitus / Q000139:chemically induced*; D006801:Humans; D008297:Male; D010419:Pentamidine / Q000009:adverse effects* / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D014409:Tumor Necrosis Factor-alpha; D010419:Pentamidine